Literature DB >> 22605908

Interviews With Two Women's Health Experts On the Use of Estrogen Therapies.

Maribeth Maher.   

Abstract

Entities:  

Year:  2012        PMID： 22605908      PMCID： PMC3351882     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


× No keyword cloud information.
  22 in total

Review 1.  Menopause: a review of botanical dietary supplements.

Authors:  Tieraona Low Dog
Journal:  Am J Med       Date:  2005-12-19       Impact factor: 4.965

2.  Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

Authors:  Jacques E Rossouw; Ross L Prentice; JoAnn E Manson; Lieling Wu; David Barad; Vanessa M Barnabei; Marcia Ko; Andrea Z LaCroix; Karen L Margolis; Marcia L Stefanick
Journal:  JAMA       Date:  2007-04-04       Impact factor: 56.272

Review 3.  Postmenopausal hormone therapy: an Endocrine Society scientific statement.

Authors:  Richard J Santen; D Craig Allred; Stacy P Ardoin; David F Archer; Norman Boyd; Glenn D Braunstein; Henry G Burger; Graham A Colditz; Susan R Davis; Marco Gambacciani; Barbara A Gower; Victor W Henderson; Wael N Jarjour; Richard H Karas; Michael Kleerekoper; Roger A Lobo; JoAnn E Manson; Jo Marsden; Kathryn A Martin; Lisa Martin; JoAnn V Pinkerton; David R Rubinow; Helena Teede; Diane M Thiboutot; Wulf H Utian
Journal:  J Clin Endocrinol Metab       Date:  2010-06-21       Impact factor: 5.958

4.  Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group.

Authors: 
Journal:  Control Clin Trials       Date:  1998-02

5.  Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study.

Authors:  R A Mulnard; C W Cotman; C Kawas; C H van Dyck; M Sano; R Doody; E Koss; E Pfeiffer; S Jin; A Gamst; M Grundman; R Thomas; L J Thal
Journal:  JAMA       Date:  2000-02-23       Impact factor: 56.272

Review 6.  Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes.

Authors:  S Mitchell Harman; Eric Vittinghoff; Eliot A Brinton; Matthew J Budoff; Marcelle I Cedars; Rogerio A Lobo; George R Merriam; Virginia M Miller; Frederick Naftolin; Lubna Pal; Nanette Santoro; Hugh S Taylor; Dennis M Black
Journal:  Am J Med       Date:  2011-03       Impact factor: 4.965

7.  Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

Authors:  Stephen R Rapp; Mark A Espeland; Sally A Shumaker; Victor W Henderson; Robert L Brunner; JoAnn E Manson; Margery L S Gass; Marcia L Stefanick; Dorothy S Lane; Jennifer Hays; Karen C Johnson; Laura H Coker; Maggie Dailey; Deborah Bowen
Journal:  JAMA       Date:  2003-05-28       Impact factor: 56.272

8.  Invited commentary: Postmenopausal unopposed estrogen and breast cancer risk in the Women's Health Initiative--before and beyond.

Authors:  Martha S Linet
Journal:  Am J Epidemiol       Date:  2008-04-29       Impact factor: 4.897

9.  Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.

Authors:  Sally A Shumaker; Claudine Legault; Lewis Kuller; Stephen R Rapp; Leon Thal; Dorothy S Lane; Howard Fillit; Marcia L Stefanick; Susan L Hendrix; Cora E Lewis; Kamal Masaki; Laura H Coker
Journal:  JAMA       Date:  2004-06-23       Impact factor: 56.272

10.  Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis.

Authors:  Charles L Loprinzi; Jeff Sloan; Vered Stearns; Rebecca Slack; Malini Iyengar; Brent Diekmann; Gretchen Kimmick; James Lovato; Paul Gordon; Kishan Pandya; Thomas Guttuso; Debra Barton; Paul Novotny
Journal:  J Clin Oncol       Date:  2009-03-30       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.